Nuclear targeting dynamics of gold nanoclusters for enhanced therapy of HER2 + breast cancer

Yuling Wang, Jiji Chen, Joseph Irudayaraj

Research output: Contribution to journalArticle

Abstract

Recent advances in fluorescent metal nanoclusters have spurred tremendous interest in nanomedicine due to the ease of fabrication, excellent biocompatibility, and, more importantly, excellent wavelength-dependent tunability. Herein, we report our findings on fluorescent BSA-protected gold nanoclusters (AuNCs), ∼2 nm in size conjugated with Herceptin (AuNCs-Her), for specific targeting and nuclear localization in ErbB2 over-expressing breast cancer cells and tumor tissue as a novel fluorescent agent for simultaneous imaging and cancer therapy. More interestingly, we found that AuNCs-Her could escape the endolysosomal pathway and enter the nucleus of cancer cells to enhance the therapeutic efficacy of Herceptin. We elucidate the diffusion characteristics (diffusion time and number of diffusers) and concentration of the fluorescing clusters in the nucleus of live cells. Our findings also suggest that the nuclear localization effect of AuNCs-Her enhances the anticancer therapeutic efficacy of Herceptin as evidenced by the induction of DNA damage. This study not only discusses a new nanomaterial platform for nuclear delivery of drugs but also provides important insights on nuclear targeting for enhanced therapy.

Original languageEnglish (US)
Pages (from-to)9718-9725
Number of pages8
JournalACS Nano
Volume5
Issue number12
DOIs
StatePublished - Dec 27 2011
Externally publishedYes

Fingerprint

Nanoclusters
Diffusers (optical)
nanoclusters
breast
Gold
therapy
cancer
Cells
Diffusers (fluid)
gold
Medical nanotechnology
Biocompatibility
Nanostructured materials
Tumors
nuclei
DNA
diffusers
biocompatibility
Tissue
Imaging techniques

Keywords

  • DNA damage
  • HER2 targeting
  • gold nanoclusters
  • nuclear nanomedicine
  • single particle characterization

ASJC Scopus subject areas

  • Materials Science(all)
  • Engineering(all)
  • Physics and Astronomy(all)

Cite this

Nuclear targeting dynamics of gold nanoclusters for enhanced therapy of HER2 + breast cancer. / Wang, Yuling; Chen, Jiji; Irudayaraj, Joseph.

In: ACS Nano, Vol. 5, No. 12, 27.12.2011, p. 9718-9725.

Research output: Contribution to journalArticle

@article{86ab584593a3480593c496046eef19b4,
title = "Nuclear targeting dynamics of gold nanoclusters for enhanced therapy of HER2 + breast cancer",
abstract = "Recent advances in fluorescent metal nanoclusters have spurred tremendous interest in nanomedicine due to the ease of fabrication, excellent biocompatibility, and, more importantly, excellent wavelength-dependent tunability. Herein, we report our findings on fluorescent BSA-protected gold nanoclusters (AuNCs), ∼2 nm in size conjugated with Herceptin (AuNCs-Her), for specific targeting and nuclear localization in ErbB2 over-expressing breast cancer cells and tumor tissue as a novel fluorescent agent for simultaneous imaging and cancer therapy. More interestingly, we found that AuNCs-Her could escape the endolysosomal pathway and enter the nucleus of cancer cells to enhance the therapeutic efficacy of Herceptin. We elucidate the diffusion characteristics (diffusion time and number of diffusers) and concentration of the fluorescing clusters in the nucleus of live cells. Our findings also suggest that the nuclear localization effect of AuNCs-Her enhances the anticancer therapeutic efficacy of Herceptin as evidenced by the induction of DNA damage. This study not only discusses a new nanomaterial platform for nuclear delivery of drugs but also provides important insights on nuclear targeting for enhanced therapy.",
keywords = "DNA damage, HER2 targeting, gold nanoclusters, nuclear nanomedicine, single particle characterization",
author = "Yuling Wang and Jiji Chen and Joseph Irudayaraj",
year = "2011",
month = "12",
day = "27",
doi = "10.1021/nn2032177",
language = "English (US)",
volume = "5",
pages = "9718--9725",
journal = "ACS Nano",
issn = "1936-0851",
publisher = "American Chemical Society",
number = "12",

}

TY - JOUR

T1 - Nuclear targeting dynamics of gold nanoclusters for enhanced therapy of HER2 + breast cancer

AU - Wang, Yuling

AU - Chen, Jiji

AU - Irudayaraj, Joseph

PY - 2011/12/27

Y1 - 2011/12/27

N2 - Recent advances in fluorescent metal nanoclusters have spurred tremendous interest in nanomedicine due to the ease of fabrication, excellent biocompatibility, and, more importantly, excellent wavelength-dependent tunability. Herein, we report our findings on fluorescent BSA-protected gold nanoclusters (AuNCs), ∼2 nm in size conjugated with Herceptin (AuNCs-Her), for specific targeting and nuclear localization in ErbB2 over-expressing breast cancer cells and tumor tissue as a novel fluorescent agent for simultaneous imaging and cancer therapy. More interestingly, we found that AuNCs-Her could escape the endolysosomal pathway and enter the nucleus of cancer cells to enhance the therapeutic efficacy of Herceptin. We elucidate the diffusion characteristics (diffusion time and number of diffusers) and concentration of the fluorescing clusters in the nucleus of live cells. Our findings also suggest that the nuclear localization effect of AuNCs-Her enhances the anticancer therapeutic efficacy of Herceptin as evidenced by the induction of DNA damage. This study not only discusses a new nanomaterial platform for nuclear delivery of drugs but also provides important insights on nuclear targeting for enhanced therapy.

AB - Recent advances in fluorescent metal nanoclusters have spurred tremendous interest in nanomedicine due to the ease of fabrication, excellent biocompatibility, and, more importantly, excellent wavelength-dependent tunability. Herein, we report our findings on fluorescent BSA-protected gold nanoclusters (AuNCs), ∼2 nm in size conjugated with Herceptin (AuNCs-Her), for specific targeting and nuclear localization in ErbB2 over-expressing breast cancer cells and tumor tissue as a novel fluorescent agent for simultaneous imaging and cancer therapy. More interestingly, we found that AuNCs-Her could escape the endolysosomal pathway and enter the nucleus of cancer cells to enhance the therapeutic efficacy of Herceptin. We elucidate the diffusion characteristics (diffusion time and number of diffusers) and concentration of the fluorescing clusters in the nucleus of live cells. Our findings also suggest that the nuclear localization effect of AuNCs-Her enhances the anticancer therapeutic efficacy of Herceptin as evidenced by the induction of DNA damage. This study not only discusses a new nanomaterial platform for nuclear delivery of drugs but also provides important insights on nuclear targeting for enhanced therapy.

KW - DNA damage

KW - HER2 targeting

KW - gold nanoclusters

KW - nuclear nanomedicine

KW - single particle characterization

UR - http://www.scopus.com/inward/record.url?scp=84555177369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84555177369&partnerID=8YFLogxK

U2 - 10.1021/nn2032177

DO - 10.1021/nn2032177

M3 - Article

C2 - 22053819

AN - SCOPUS:84555177369

VL - 5

SP - 9718

EP - 9725

JO - ACS Nano

JF - ACS Nano

SN - 1936-0851

IS - 12

ER -